Sabeena Choudhary

percist recist lugano ind drug approval new drug development drug brca ovarian cancer paola trial solo 1 olaparib response evaluat response evaluation in cancer response eval in lymphoma lymphoma response assessment lymphoma response ann arbor costwolds response adr adverse drug reaction fda approval priority review fast track breakthrough approval accelerated drug approval phases clinical trial